PTPI — Petros Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Petros Pharmaceuticals Files For Resale Of Up To 3.8 Million Shares
Brief: Petros Pharmaceuticals Announces Positive Over-The-Counter Label Comprehension Study Results For Erectile Dysfunction Drug Stendra
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:51 PM
U.S. STOCKS ON THE MOVE-Didi, MEI Pharma, TG Therapeutics, Cumberland Pharma
NASDAQ RESUMED AT 09:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Petros Pharma plunges on $10 mln equity offering
Brief: Petros Pharmaceuticals Announces $10 Million Offering
U.S. STOCKS ON THE MOVE-Euroseas Ltd, iBio, Berry Global, Chegg
Petros Pharma, Biofrontera trade in high vols, retail attention persists
U.S. STOCKS ON THE MOVE-Apple, Zoom, Abercrombie, Walt Disney
U.S. STOCKS ON THE MOVE-Zoom, Udemy, Walt Disney
Biotechs iSpecimen, Qualigen, Longeveron jump as retail investor chatter grows
Brief: Petros Pharmaceuticals Reports Q3 Sales Of $2.2 Mln
Brief: Petros Pharmaceuticals Inc - Files Prospectus Related To Resale By Selling Stockholders From Time To Time Of Up To 3.5 Million Shares Of Common Stock
Brief: Petros Pharmaceuticals Expands Program For Peyronie's Disease Investigational Treatment
Brief: Petros Pharmaceuticals Inc Announces $5.7 Mln Registered Direct Offering
Brief: Petros Pharmaceuticals Announces Second Quarter Financial Results
Petros Pharma: Rises as mid-stage study begins for erectile dysfunction drug